Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC janvier 12, 20240CommentsEN NL Read More
Jaarverslag 2023 (officiële ESEF-versie) décembre 30, 20230CommentsJaarverslag 2023 (officiële ESEF-versie)Read More
Rapport Annuel 2023 (version officielle ESEF) décembre 30, 20230CommentsRapport Annuel 2023 (version officielle ESEF)Read More
Oxurion Avoids Bankruptcy, Announces Board and Management Changes and Enters into Binding Letter of Intent with its Main Creditor Atlas décembre 28, 20230CommentsEN NL Read More
Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC décembre 1, 20230CommentsEN NL Read More
Oxurion Discloses Topline Data from KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular Edema novembre 20, 20230CommentsEN NL Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas novembre 19, 20230CommentsEN NL Read More
Oxurion Receives EUR 1.0 Million under Amended Atlas Funding Program Total of EUR 3.5 Million in Unconditional Funding Allowing Company to Reach Topline Data from KALAHARI Trial This Year novembre 16, 20230CommentsEN Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas novembre 16, 20230CommentsEN NL Read More
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC novembre 15, 20230CommentsEN NL Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas novembre 6, 20230CommentsEN NL Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas novembre 3, 20230CommentsEN NL Read More
Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC octobre 30, 20230CommentsEN NL Read More
Oxurion Receives EUR 1.5 Million under Amended Atlas Funding Program; Total of EUR 3.5 Million in Unconditional Funding Allowing Company to Achieve Topline Data from KALAHARI Trial octobre 25, 20230CommentsEN Read More
Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC octobre 20, 20230CommentsEN NL Read More
